Literature DB >> 11390266

Mixed micelles containing lipophilic gadolinium complexes as MRA contrast agents.

P L Anelli1, L Lattuada, V Lorusso, M Schneider, H Tournier, F Uggeri.   

Abstract

Mixed micelles for MRA are multicomponent systems containing a phospholipid, a biocompatible non-ionic surfactant (e.g. Synperonic(R) F-108) and a lipophilic gadolinium complex. A variety of lipophilic gadolinium complexes were designed taking into account features such as: (i) nature of ligand (cyclic versus acyclic); (ii) lipophilic moiety; (iii) global charge of the complex; and (iv) nature of bond connecting the complex to the lipophilic moiety. All the lipophilic gadolinium complexes after formulation as mixed micelles show high relaxivities in water and in blood (rat). Mixed micelles containing gadolinium complexes bearing only one aliphatic chain cannot be used as MRA contrast agents because they have a high haemolytic effect. Furthermore, in rats they are quickly eliminated from the blood stream. These drawbacks are completely circumvented using gadolinium complexes bearing two aliphatic chains. Mixed micelles containing such complexes show high relaxivities, no haemolytic effect and long blood permanence. This makes them promising candidates as MRA contrast agents. However, elimination, which occurs exclusively through the liver, is not complete, even after 7 days. Complexes containing labile (e.g. ester) bonds between the lipophilic moieties and the chelate subunit are eliminated through both the liver and the kidneys. However, elimination is still not complete after 7 days.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390266     DOI: 10.1007/bf02668092

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  11 in total

1.  Gadolinium-containing mixed micelle formulations: a new class of blood pool MRI/MRA contrast agents.

Authors:  Hervé Tournier; Roland Hyacinthe; Michel Schneider
Journal:  Acad Radiol       Date:  2002-05       Impact factor: 3.173

2.  New compounds: fatty acid and long chain hydrocarbon derivatives containing a strong chelating agent.

Authors:  W C Eckelman; S M Karesh; R C Reba
Journal:  J Pharm Sci       Date:  1975-04       Impact factor: 3.534

Review 3.  Contrast-enhanced magnetic resonance imaging of the coronary arteries. A review.

Authors:  D Li; J Zheng; K T Bae; P K Woodard; E M Haacke
Journal:  Invest Radiol       Date:  1998-09       Impact factor: 6.016

Review 4.  The future of contrast-enhanced magnetic resonance angiography. Are blood pool agents needed?

Authors:  A Mühler
Journal:  Invest Radiol       Date:  1998-09       Impact factor: 6.016

5.  Magnetic resonance angiography with gadomer-17. An animal study original investigation.

Authors:  Q Dong; D R Hurst; H J Weinmann; T L Chenevert; F J Londy; M R Prince
Journal:  Invest Radiol       Date:  1998-09       Impact factor: 6.016

6.  L-Glutamic acid and L-lysine as useful building blocks for the preparation of bifunctional DTPA-like ligands.

Authors:  P L Anelli; F Fedeli; O Gazzotti; L Lattuada; G Lux; F Rebasti
Journal:  Bioconjug Chem       Date:  1999 Jan-Feb       Impact factor: 4.774

7.  MS-325: albumin-targeted contrast agent for MR angiography.

Authors:  R B Lauffer; D J Parmelee; S U Dunham; H S Ouellet; R P Dolan; S Witte; T J McMurry; R C Walovitch
Journal:  Radiology       Date:  1998-05       Impact factor: 11.105

Review 8.  Assessment of myocardial perfusion using contrast-enhanced MR imaging: current status and future developments.

Authors:  A Mühler
Journal:  MAGMA       Date:  1995-03       Impact factor: 2.310

Review 9.  Status of liposomes as MR contrast agents.

Authors:  E C Unger; D K Shen; T A Fritz
Journal:  J Magn Reson Imaging       Date:  1993 Jan-Feb       Impact factor: 4.813

10.  Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.

Authors:  D L Ladd; R Hollister; X Peng; D Wei; G Wu; D Delecki; R A Snow; J L Toner; K Kellar; J Eck; V C Desai; G Raymond; L B Kinter; T S Desser; D L Rubin
Journal:  Bioconjug Chem       Date:  1999 May-Jun       Impact factor: 4.774

View more
  7 in total

1.  Strategies for the preparation of bifunctional gadolinium(III) chelators.

Authors:  Luca Frullano; Peter Caravan
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

2.  High-relaxivity supramolecular aggregates containing peptides and Gd complexes as contrast agents in MRI.

Authors:  Antonella Accardo; Diego Tesauro; Giancarlo Morelli; Eliana Gianolio; Silvio Aime; Mauro Vaccaro; Gaetano Mangiapia; Luigi Paduano; Karin Schillén
Journal:  J Biol Inorg Chem       Date:  2006-11-03       Impact factor: 3.358

3.  Paramagnetic liposomes containing amphiphilic bisamide derivatives of Gd-DTPA with aromatic side chain groups as possible contrast agents for magnetic resonance imaging.

Authors:  Tatjana N Parac-Vogt; Kristof Kimpe; Sophie Laurent; Corinne Piérart; Luce Vander Elst; Robert N Muller; Koen Binnemans
Journal:  Eur Biophys J       Date:  2005-10-11       Impact factor: 1.733

4.  Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents.

Authors:  Sang Young Jeong; Hyo Jeong Kim; Byung-Kook Kwak; Ha-Young Lee; Hasoo Seong; Byung Cheol Shin; Soon Hong Yuk; Sung-Joo Hwang; Sun Hang Cho
Journal:  Nanoscale Res Lett       Date:  2010-09-02       Impact factor: 4.703

5.  High-relaxivity gadolinium-modified high-density lipoproteins as magnetic resonance imaging contrast agents.

Authors:  Karen C Briley-Saebo; Simonetta Geninatti-Crich; David P Cormode; Alessandra Barazza; Willem J M Mulder; Wei Chen; Giovanni B Giovenzana; Edward A Fisher; Silvio Aime; Zahi A Fayad
Journal:  J Phys Chem B       Date:  2009-05-07       Impact factor: 2.991

6.  MRI tracking of macrophages labeled with glucan particles entrapping a water insoluble paramagnetic Gd-based agent.

Authors:  Sara Figueiredo; Juan Carlos Cutrin; Silvia Rizzitelli; Elisa De Luca; João Nuno Moreira; Carlos F G C Geraldes; Silvio Aime; Enzo Terreno
Journal:  Mol Imaging Biol       Date:  2013-06       Impact factor: 3.488

7.  Gadolinium(III) Complexes with N-Alkyl-N-methylglucamine Surfactants Incorporated into Liposomes as Potential MRI Contrast Agents.

Authors:  Simone Rodrigues Silva; Érica Correia Duarte; Guilherme Santos Ramos; Flávio Vinícius Crizóstomo Kock; Fabiana Diuk Andrade; Frédéric Frézard; Luiz Alberto Colnago; Cynthia Demicheli
Journal:  Bioinorg Chem Appl       Date:  2015-08-10       Impact factor: 7.778

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.